ImmunityBio (IBRX)
Healthcare · Biotechnology
2 members of Congress have disclosed 3 trades in ImmunityBio (IBRX) since 2023: 2 buys and 1 sale. The most recent was disclosed on Oct 12, 2026.
- Trades disclosed
- 3
- Members trading
- 2
- Buys / sells
- 2 / 1
- Reported value
- $3K–$45K
Keep following the company.
Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.
What else is happening at IBRX
All research →Company filings and public records connected to this stock, ordered by when they became public or were first observed.
IBRX: Company disclosure
Filed 8-K for an event or period dated 2026-10-14. Company disclosure.
1 congressional household disclosed purchases in the past 90 days. See the trades
Who traded IBRX
- Rep. Lisa C. McClain (R-MI-9)2 buys · 0 sales20Oct 12, 2026
- Rep. Daniel S. Goldman (D-NY-10)0 buys · 1 sale01Apr 17, 2023
All trades
- Oct 12, 2026$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Sep 30, 2026 · disclosed Oct 12, 2026 · Spouse
- Oct 12, 2026$1K–$15K
Rep. Lisa C. McClain (R-MI-9)
$1K–$15K · Traded Sep 28, 2026 · disclosed Oct 12, 2026 · Spouse
- Apr 17, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
$1K–$15K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.